Liom
Liom has created a non-invasive, wearable laser spectroscopy system capable of continuously measuring blood glucose and other biomarkers without blood draws, targeting the diabetic market and preventive metabolic health monitoring.
Europe's most interesting startup stories. Every week.
No spam. Unsubscribe anytime.
Podcast Episode
🎙️ Deep Dive
Daily News - 19 December 2025
Listen to the episodeAbout Liom
Liom is a Swiss medtech startup founded in 2017 developing near-infrared laser spectroscopy technology in wearable format for non-invasive continuous blood glucose measurement. In December 2025 it raised a EUR 13.9M Series A extension with investors including Zürcher Kantonalbank to accelerate clinical validation and CE certification.
Market & Clients
Key Customers
Diabetic patients, European healthcare systems and metabolic health-conscious consumers seeking non-invasive alternatives to traditional blood glucose monitoring.
Geographic Presence
Funding & Investors
Funding Rounds
- 2025 - Series A: euro13M
Key Investors
Similar Startups
ALP Bio
ALP Bio combines human immune organoids and generative AI to predict and reduce immunogenicity risk in antibody development.
Read AnalysisWearable Robotics
Closed €5M Series A to expand exoskeletons and robotic devices for neuromotor rehabilitation—clinical and post-trauma recovery applications.
Read AnalysisCELLEVATE AB
Transforming bioproduction through advanced cell therapy technology for scalable manufacturing.
Read Analysis